Salvatore Thomas Butera insider trades

Open-market stock purchases and sales by Salvatore Thomas Butera, CEO - Volition Veterinary at Volitionrx Ltd, from SEC Form 4 filings since Dec 1, 2020.

Track record: 33% of 12 scored buys are up 5% or more since purchase, averaging -1%.

Recent trades

DateStockTradeValue
Jan 22, 2026VNRX Volitionrx LtdBought (not open market)—
Nov 1, 2025VNRX Volitionrx LtdSold (not open market)$2K
Oct 4, 2025VNRX Volitionrx LtdSold (not open market)$3.8K

Companies traded

  • VNRX Volitionrx Ltd: 12 buys, last Jan 22, 2026

Get free alerts when Salvatore Thomas Butera files a new trade →